Manchester Capital Management’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-209
Closed -$1K 1186
2022
Q1
$1K Sell
209
-20
-9% -$171 ﹤0.01% 1011
2021
Q4
$2K Buy
229
+165
+258% +$1.53K ﹤0.01% 894
2021
Q3
$1K Buy
+64
New +$702 ﹤0.01% 1015
2014
Q2
Sell
-100
Closed -$4K 1110
2014
Q1
$4K Buy
+100
New +$3.6K ﹤0.01% 928
2013
Q4
Sell
-275
Closed -$8K 969
2013
Q3
$8K Buy
+275
New +$8.62K ﹤0.01% 858

Other funds holding DBD

Manchester Capital Management's DBD Position: Q2 2022 in Review

Manchester Capital Management sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2022, closing a stake of 209 shares — an estimated $1K sold.

Manchester Capital Management first reported a position in DBD in Q3 2013 and held it in 5 quarters. The position peaked at $8K in Q3 2013. 169 funds tracked by Wall St. Rank hold DBD as of Q2 2022.

  • Manchester Capital Management reported no remaining Diebold Nixdorf Incorporated position as of Q2 2022 after selling out during the quarter.
  • Manchester Capital Management sold 209 Diebold Nixdorf Incorporated shares in Q2 2022, an estimated $1K.
  • Manchester Capital Management first reported a position in Diebold Nixdorf Incorporated in Q3 2013 and held it in 5 quarters.
  • Manchester Capital Management's Diebold Nixdorf Incorporated position peaked at $8K in Q3 2013.
  • 169 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2022.

Based on Manchester Capital Management's 13F filing for Q2 2022, filed 10 Aug 2022.